316 related articles for article (PubMed ID: 34680938)
1. Genetic and Genomic Pathways of Melanoma Development, Invasion and Metastasis.
Motwani J; Eccles MR
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680938
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor of DNA Binding 4 (ID4) is highly expressed in human melanoma tissues and may function to restrict normal differentiation of melanoma cells.
Peretz Y; Wu H; Patel S; Bellacosa A; Katz RA
PLoS One; 2015; 10(2):e0116839. PubMed ID: 25642713
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression.
Pessoa DO; Rius FE; Papaiz DD; Ayub ALP; Morais AS; de Souza CF; da Paixão VF; Setubal JC; Newton-Bishop J; Nsengimana J; Azevedo H; Reis EM; Jasiulionis MG
Neoplasia; 2021 Apr; 23(4):439-455. PubMed ID: 33845354
[TBL] [Abstract][Full Text] [Related]
4. The role of Wnt/β-catenin signaling pathway in melanoma epithelial-to-mesenchymal-like switching: evidences from patients-derived cell lines.
Kovacs D; Migliano E; Muscardin L; Silipo V; Catricalà C; Picardo M; Bellei B
Oncotarget; 2016 Jul; 7(28):43295-43314. PubMed ID: 27175588
[TBL] [Abstract][Full Text] [Related]
5. Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.
Cheng PF; Shakhova O; Widmer DS; Eichhoff OM; Zingg D; Frommel SC; Belloni B; Raaijmakers MI; Goldinger SM; Santoro R; Hemmi S; Sommer L; Dummer R; Levesque MP
Genome Biol; 2015 Feb; 16(1):42. PubMed ID: 25885555
[TBL] [Abstract][Full Text] [Related]
6. NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF.
Fane ME; Chhabra Y; Hollingsworth DEJ; Simmons JL; Spoerri L; Oh TG; Chauhan J; Chin T; Harris L; Harvey TJ; Muscat GEO; Goding CR; Sturm RA; Haass NK; Boyle GM; Piper M; Smith AG
EBioMedicine; 2017 Feb; 16():63-75. PubMed ID: 28119061
[TBL] [Abstract][Full Text] [Related]
7. Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma.
Fattore L; Ruggiero CF; Liguoro D; Mancini R; Ciliberto G
Cell Death Dis; 2019 Oct; 10(11):827. PubMed ID: 31672982
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation in human melanoma: past and future.
Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous tumor subpopulations cooperate to drive invasion.
Chapman A; Fernandez del Ama L; Ferguson J; Kamarashev J; Wellbrock C; Hurlstone A
Cell Rep; 2014 Aug; 8(3):688-95. PubMed ID: 25066122
[TBL] [Abstract][Full Text] [Related]
11. BRN2, a POUerful driver of melanoma phenotype switching and metastasis.
Fane ME; Chhabra Y; Smith AG; Sturm RA
Pigment Cell Melanoma Res; 2019 Jan; 32(1):9-24. PubMed ID: 29781575
[TBL] [Abstract][Full Text] [Related]
12. Making a melanoma: Molecular and cellular changes underlying melanoma initiation.
Darp R; Ceol C
Pigment Cell Melanoma Res; 2021 Mar; 34(2):280-287. PubMed ID: 33283422
[TBL] [Abstract][Full Text] [Related]
13. Epigenomic landscape of melanoma progression to brain metastasis: unexplored therapeutic alternatives.
Marzese DM; Witz IP; Kelly DF; Hoon DS
Epigenomics; 2015; 7(8):1303-11. PubMed ID: 26638944
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia contributes to melanoma heterogeneity by triggering HIF1α-dependent phenotype switching.
Widmer DS; Hoek KS; Cheng PF; Eichhoff OM; Biedermann T; Raaijmakers MIG; Hemmi S; Dummer R; Levesque MP
J Invest Dermatol; 2013 Oct; 133(10):2436-2443. PubMed ID: 23474946
[TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic alterations of the APC gene in malignant melanoma.
Worm J; Christensen C; Grønbaek K; Tulchinsky E; Guldberg P
Oncogene; 2004 Jul; 23(30):5215-26. PubMed ID: 15133491
[TBL] [Abstract][Full Text] [Related]
16. Whole transcriptome analysis reveals correlation of long noncoding RNA ZEB1-AS1 with invasive profile in melanoma.
Siena ÁDD; Plaça JR; Araújo LF; de Barros II; Peronni K; Molfetta G; de Biagi CAO; Espreafico EM; Sousa JF; Silva WA
Sci Rep; 2019 Aug; 9(1):11350. PubMed ID: 31383874
[TBL] [Abstract][Full Text] [Related]
17. Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.
Harbst K; Staaf J; Måsbäck A; Olsson H; Ingvar C; Vallon-Christersson J; Ringnér M; Borg A; Jönsson G
Melanoma Res; 2010 Oct; 20(5):381-91. PubMed ID: 20848731
[TBL] [Abstract][Full Text] [Related]
18. Emerging molecular targets in melanoma invasion and metastasis.
Orgaz JL; Sanz-Moreno V
Pigment Cell Melanoma Res; 2013 Jan; 26(1):39-57. PubMed ID: 23095214
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-to-mesenchymal-like transition events in melanoma.
Pedri D; Karras P; Landeloos E; Marine JC; Rambow F
FEBS J; 2022 Mar; 289(5):1352-1368. PubMed ID: 33999497
[TBL] [Abstract][Full Text] [Related]
20. Melanoma Suppressor Functions of the Carcinoma Oncogene FOXQ1.
Bagati A; Bianchi-Smiraglia A; Moparthy S; Kolesnikova K; Fink EE; Lipchick BC; Kolesnikova M; Jowdy P; Polechetti A; Mahpour A; Ross J; Wawrzyniak JA; Yun DH; Paragh G; Kozlova NI; Berman AE; Wang J; Liu S; Nemeth MJ; Nikiforov MA
Cell Rep; 2017 Sep; 20(12):2820-2832. PubMed ID: 28930679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
